GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Peritoneal Cancer.